{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:45:09Z","timestamp":1791380709487,"version":"4.3.3"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81270865"],"award-info":[{"award-number":["81270865"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2016M600596"],"award-info":[{"award-number":["2016M600596"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.biopha.2017.08.127","type":"journal-article","created":{"date-parts":[[2017,9,8]],"date-time":"2017-09-08T02:30:27Z","timestamp":1504837827000},"page":"771-779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Triptolide suppresses growth and hormone secretion in murine pituitary corticotroph tumor cells via NF-kappaB signaling pathway"],"prefix":"10.1016","volume":"95","author":[{"given":"Ran","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9522","key":"10.1016\/j.biopha.2017.08.127_bib0005","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing's syndrome","volume":"367","author":"Newell-Price","year":"2006","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.biopha.2017.08.127_bib0010","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1210\/jc.2007-2734","article-title":"Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement","volume":"93","author":"Biller","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9996","key":"10.1016\/j.biopha.2017.08.127_bib0015","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing's syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2017.08.127_bib0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/13543784.2017.1266338","article-title":"Currently used and investigational drugs for Cushing s disease","volume":"26","author":"Ciato","year":"2017","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"6","key":"10.1016\/j.biopha.2017.08.127_bib0025","first-page":"307","article-title":"Surgery Remission after transsphenoidal surgery for Cushing disease, Nature reviews","volume":"6","author":"Marko","year":"2010","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.biopha.2017.08.127_bib0030","first-page":"279","article-title":"Management of Cushing disease, nature reviews","volume":"7","author":"Tritos","year":"2011","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.biopha.2017.08.127_bib0035","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cell.2007.08.021","article-title":"Molecular understanding and modern application of traditional medicines: triumphs and trials","volume":"130","author":"Corson","year":"2007","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biopha.2017.08.127_bib0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jep.2014.06.006","article-title":"Triptolide: progress on research in pharmacodynamics and toxicology","volume":"155","author":"Li","year":"2014","journal-title":"J. Ethnopharmacol."},{"issue":"47","key":"10.1016\/j.biopha.2017.08.127_bib0045","doi-asserted-by":"crossref","first-page":"33927","DOI":"10.1074\/jbc.M113.500983","article-title":"Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1","volume":"288","author":"Banerjee","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"156","key":"10.1016\/j.biopha.2017.08.127_bib0050","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004334","article-title":"A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer","volume":"4","author":"Chugh","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"10.1016\/j.biopha.2017.08.127_bib0055","doi-asserted-by":"crossref","first-page":"8027","DOI":"10.1021\/nn502074x","article-title":"pH-sensitive nanoformulated triptolide as a targeted therapeutic strategy for hepatocellular carcinoma","volume":"8","author":"Ling","year":"2014","journal-title":"ACS Nano"},{"issue":"19","key":"10.1016\/j.biopha.2017.08.127_bib0060","doi-asserted-by":"crossref","first-page":"9407","DOI":"10.1158\/0008-5472.CAN-07-1077","article-title":"Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70","volume":"67","author":"Phillips","year":"2007","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.biopha.2017.08.127_bib0065","first-page":"551","article-title":"Triptolide induces apoptosis in human adrenal cancer NCI-H295 cells through a mitochondrial-dependent pathway","volume":"25","author":"Wu","year":"2011","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2017.08.127_bib0070","first-page":"65","article-title":"Triptolide inhibits the growth and metastasis of solid tumors","volume":"2","author":"Yang","year":"2003","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/j.biopha.2017.08.127_bib0075","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/cns.12039","article-title":"Triptolide with potential medicinal value for diseases of the central nervous system","volume":"19","author":"Zheng","year":"2013","journal-title":"Cns Neurosci. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2017.08.127_bib0080","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.it.2004.03.008","article-title":"The two NF-kappaB activation pathways and their role in innate and adaptive immunity","volume":"25","author":"Bonizzi","year":"2004","journal-title":"Trends Immunol."},{"issue":"7092","key":"10.1016\/j.biopha.2017.08.127_bib0085","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature04870","article-title":"Nuclear factor-kappaB in cancer development and progression","volume":"441","author":"Karin","year":"2006","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2017.08.127_bib0090","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/embr.201337983","article-title":"The IkappaB kinase complex in NF-kappaB regulation and beyond","volume":"15","author":"Hinz","year":"2014","journal-title":"EMBO Rep."},{"issue":"2","key":"10.1016\/j.biopha.2017.08.127_bib0095","first-page":"121","article-title":"The diverse and complex roles of NF-kappaB subunits in cancer, Nature reviews","volume":"12","author":"Perkins","year":"2012","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2017.08.127_bib0100","doi-asserted-by":"crossref","first-page":"e9893","DOI":"10.1371\/journal.pone.0009893","article-title":"Growth suppression of mouse pituitary corticotroph tumor AtT20 cells by curcumin: a model for treating Cushing's disease","volume":"5","author":"Bangaru","year":"2010","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.biopha.2017.08.127_bib0105","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.3892\/mmr.2014.2078","article-title":"Ursolic acid suppresses growth and adrenocorticotrophic hormone secretion in AtT20 cells as a potential agent targeting adrenocorticotrophic hormone-producing pituitary adenoma","volume":"9","author":"Gong","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2017.08.127_bib0110","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1227\/01.NEU.0000312715.01310.49","article-title":"Inhibition of NFkappaB reduces cellular viability in GH3 pituitary adenoma cells","volume":"62","author":"Vender","year":"2008","journal-title":"Neurosurgery"},{"issue":"9","key":"10.1016\/j.biopha.2017.08.127_bib0115","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/jne.12296","article-title":"Lack of oestrogenic inhibition of the nuclear factor-kappaB pathway in somatolactotroph tumour cells","volume":"27","author":"Eijo","year":"2015","journal-title":"J. Neuroendocrinol."},{"issue":"11","key":"10.1016\/j.biopha.2017.08.127_bib0120","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1073\/pnas.0700499104","article-title":"Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease","volume":"104","author":"Leuenroth","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.biopha.2017.08.127_bib0125","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1039\/c2np00088a","article-title":"Triptolide: structural modifications, structure-activity relationships, bioactivities, clinical development and mechanisms","volume":"29","author":"Zhou","year":"2012","journal-title":"Nat. Prod. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2017.08.127_bib0130","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.phytochem.2006.11.029","article-title":"Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae)","volume":"68","author":"Brinker","year":"2007","journal-title":"Phytochemistry"},{"issue":"1","key":"10.1016\/j.biopha.2017.08.127_bib0135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jep.2011.12.041","article-title":"Fighting fire with fire: poisonous Chinese herbal medicine for cancer therapy","volume":"140","author":"Wang","year":"2012","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2017.08.127_bib0140","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.intimp.2011.01.012","article-title":"Triptolide and its expanding multiple pharmacological functions","volume":"11","author":"Liu","year":"2011","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2017.08.127_bib0145","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1142\/S0192415X05003521","article-title":"Effects of the extract of a Chinese herb Tripterygium wilfordii hook f on rat pituitary gland","volume":"33","author":"Chen","year":"2005","journal-title":"Am. J. Chin. Med."},{"issue":"1","key":"10.1016\/j.biopha.2017.08.127_bib0150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrd2781","article-title":"Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls, Nature reviews","volume":"8","author":"Baud","year":"2009","journal-title":"Drug Discov."},{"issue":"4","key":"10.1016\/j.biopha.2017.08.127_bib0155","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1124\/mol.108.052605","article-title":"A small-molecule triptolide suppresses angiogenesis and invasion of human anaplastic thyroid carcinoma cells via down-regulation of the nuclear factor-kappa B pathway","volume":"75","author":"Zhu","year":"2009","journal-title":"Mol. Pharmacol."},{"issue":"12","key":"10.1016\/j.biopha.2017.08.127_bib0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17122139","article-title":"Triptolide combined with radiotherapy for the treatment of nasopharyngeal carcinoma via NF-kappaB-related mechanism","volume":"17","author":"Zhang","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2017.08.127_bib0165","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3892\/ijo.2013.2033","article-title":"Triptolide induces apoptosis of PMA-treated THP-1 cells through activation of caspases, inhibition of NF-kappaB and activation of MAPKs","volume":"43","author":"Park","year":"2013","journal-title":"Int. J. Oncol."},{"issue":"10","key":"10.1016\/j.biopha.2017.08.127_bib0170","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1002\/ijc.28583","article-title":"Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-kappaB downregulation","volume":"134","author":"Liu","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2017.08.127_bib0175","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1142\/S0192415X14500323","article-title":"Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-kappaB signaling in glioma initiating cells","volume":"42","author":"Sai","year":"2014","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.biopha.2017.08.127_bib0180","doi-asserted-by":"crossref","first-page":"350239","DOI":"10.1155\/2012\/350239","article-title":"Triptolide transcriptionally represses HER2 in ovarian cancer cells by targeting NF-kappaB","volume":"2012","author":"Ou","year":"2012","journal-title":"Evid. Based Complem. Altern. Med.: eCAM"},{"issue":"4","key":"10.1016\/j.biopha.2017.08.127_bib0185","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.amjsurg.2013.01.008","article-title":"Triptolide-mediated cell death in neuroblastoma occurs by both apoptosis and autophagy pathways and results in inhibition of nuclear factor-kappa B activity","volume":"205","author":"Krosch","year":"2013","journal-title":"Am. J. Surg."},{"issue":"2","key":"10.1016\/j.biopha.2017.08.127_bib0190","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1074\/jbc.M208696200","article-title":"The NF-kappa B activation in lymphotoxin beta receptor signaling depends on the phosphorylation of p65 at serine 536","volume":"278","author":"Jiang","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"18","key":"10.1016\/j.biopha.2017.08.127_bib0195","doi-asserted-by":"crossref","first-page":"18137","DOI":"10.1074\/jbc.M401397200","article-title":"Human T-cell lymphotropic virus type 1 tax induction of biologically Active NF-kappaB requires IkappaB kinase-1-mediated phosphorylation of RelA\/p65","volume":"279","author":"O'Mahony","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"25","key":"10.1016\/j.biopha.2017.08.127_bib0200","doi-asserted-by":"crossref","first-page":"26115","DOI":"10.1074\/jbc.M313509200","article-title":"p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1","volume":"279","author":"Bohuslav","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.biopha.2017.08.127_bib0205","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1158\/0008-5472.CAN-04-3494","article-title":"Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB-dependent transcription in cancer cells","volume":"65","author":"Ho","year":"2005","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.biopha.2017.08.127_bib0210","doi-asserted-by":"crossref","first-page":"600","DOI":"10.4161\/auto.6260","article-title":"Bcl-2 family members: dual regulators of apoptosis and autophagy","volume":"4","author":"Levine","year":"2008","journal-title":"Autophagy"},{"issue":"12","key":"10.1016\/j.biopha.2017.08.127_bib0215","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/sj.cdd.4401497","article-title":"Apoptosis and disease: a matter of cell fate","volume":"11","author":"Hague","year":"2004","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.biopha.2017.08.127_bib0220","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0006-291X(03)00615-6","article-title":"Mechanisms of cytochrome c release by proapoptotic BCL-2 family members","volume":"304","author":"Scorrano","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.biopha.2017.08.127_bib0225","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jnci.2011.11.003","article-title":"Differential expression of cyclin D1 in human pituitary tumors: relation to MIB-1 and p27\/Kip1 labeling indices","volume":"23","author":"Hewedi","year":"2011","journal-title":"J. Egypt Natl. Canc. Inst."},{"issue":"3\u20134","key":"10.1016\/j.biopha.2017.08.127_bib0230","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.wneu.2013.09.035","article-title":"Results of immunohistochemical staining of cell-cycle regulators: the prediction of recurrence of functioning pituitary adenoma","volume":"81","author":"Lee","year":"2014","journal-title":"World Neurosurg."},{"issue":"2","key":"10.1016\/j.biopha.2017.08.127_bib0235","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1677\/joe.1.06418","article-title":"Suppressive effects of dehydroepiandrosterone and the nuclear factor-kappaB inhibitor parthenolide on corticotroph tumor cell growth and function in vitro and in vivo","volume":"188","author":"Taguchi","year":"2006","journal-title":"J. Endocrinol."},{"issue":"2","key":"10.1016\/j.biopha.2017.08.127_bib0240","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1677\/JOE-08-0011","article-title":"Interferon-gamma inhibits cellular proliferation and ACTH production in corticotroph tumor cells through a novel janus kinases-signal transducer and activator of transcription 1\/nuclear factor-kappa B inhibitory signaling pathway","volume":"199","author":"Labeur","year":"2008","journal-title":"J. Endocrinol."},{"issue":"2","key":"10.1016\/j.biopha.2017.08.127_bib0245","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000258691","article-title":"Involvement of nuclear factor-kB and Nurr-1 in cytokine-induced transcription of proopiomelanocortin gene in AtT20 corticotroph cells","volume":"17","author":"Takayasu","year":"2010","journal-title":"Neuroimmunomodulation"},{"issue":"3","key":"10.1016\/j.biopha.2017.08.127_bib0250","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ejca.2011.11.002","article-title":"Targeting Raf\/MEK\/ERK pathway in pituitary adenomas","volume":"48","author":"Suojun","year":"2012","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2017.08.127_bib0255","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3340\/jkns.2009.46.4.389","article-title":"Triptolide inhibits the proliferation of immortalized HT22 hippocampal cells via persistent activation of extracellular signal-regulated kinase-1\/2 by down-regulating mitogen-activated protein kinase phosphatase-1 expression","volume":"46","author":"Koo","year":"2009","journal-title":"J. Korean Neurosurg. Soc."},{"issue":"42","key":"10.1016\/j.biopha.2017.08.127_bib0260","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3892\/ijo.2013.1843","article-title":"Role of oxidative stress, endoplasmic reticulum stress and ERK activation in triptolide-induced apoptosis","volume":"5","author":"Tan","year":"2013","journal-title":"Int. J. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2017.08.127_bib0265","doi-asserted-by":"crossref","first-page":"192","DOI":"10.18632\/aging.100296","article-title":"Roles of the Raf\/MEK\/ERK and PI3K\/PTEN\/Akt\/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging","volume":"3","author":"Steelman","year":"2011","journal-title":"Aging (Milano)"},{"issue":"2","key":"10.1016\/j.biopha.2017.08.127_bib0270","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1203421","article-title":"Improved survival with MEK inhibition in BRAF-mutated melanoma","volume":"367","author":"Flaherty","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2017.08.127_bib0275","doi-asserted-by":"crossref","first-page":"6685","DOI":"10.1038\/ncomms7685","article-title":"The nuclear translocation of ERK1\/2 as an anticancer target","volume":"6","author":"Plotnikov","year":"2015","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2017.08.127_bib0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1074\/mcp.M114.037697","article-title":"Proteomic analysis reveals a role for Bcl2-associated athanogene 3 and major vault protein in resistance to apoptosis in senescent cells by regulating ERK1\/2 activation","volume":"14","author":"Pasillas","year":"2015","journal-title":"Mol. Cell. Proteomics"},{"issue":"8","key":"10.1016\/j.biopha.2017.08.127_bib0285","doi-asserted-by":"crossref","first-page":"9175","DOI":"10.18632\/oncotarget.7037","article-title":"Cold inducible RNA binding protein upregulation in pituitary corticotroph adenoma induces corticotroph cell proliferation via Erk signaling pathway","volume":"7","author":"Jian","year":"2016","journal-title":"Oncotarget"},{"issue":"43","key":"10.1016\/j.biopha.2017.08.127_bib0290","doi-asserted-by":"crossref","first-page":"69149","DOI":"10.18632\/oncotarget.12381","article-title":"Targeting the ERK pathway for the treatment of Cushing's disease","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.biopha.2017.08.127_bib0295","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/cr.2015.20","article-title":"Recurrent gain-of-function USP8 mutations in Cushing's disease","volume":"25","author":"Ma","year":"2015","journal-title":"Cell Res."},{"issue":"7","key":"10.1016\/j.biopha.2017.08.127_bib0300","doi-asserted-by":"crossref","first-page":"E997","DOI":"10.1210\/jc.2015-1453","article-title":"The gene of the ubiquitin-specific protease 8 is frequently mutated in adenomas causing Cushing's disease","volume":"100","author":"Perez-Rivas","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2017.08.127_bib0305","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ng.3166","article-title":"Mutations in the deubiquitinase gene USP8 cause Cushing's disease","volume":"47","author":"Reincke","year":"2015","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.biopha.2017.08.127_bib0310","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1172\/JCI60417","article-title":"EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas","volume":"121","author":"Fukuoka","year":"2011","journal-title":"J. Clin. Invest."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217337563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217337563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T07:48:48Z","timestamp":1771400928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217337563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":62,"alternative-id":["S0753332217337563"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.08.127","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triptolide suppresses growth and hormone secretion in murine pituitary corticotroph tumor cells via NF-kappaB signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.08.127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}